To view more details, including parent strains and references, click on the corresponding dictyBase ID.
| Systematic Name | Strain Descriptor | Associated gene(s) | Phenotypes |
|---|---|---|---|
| DBS0351382 | myoB-/ [act15]: GFP: myoB(1-921,1057-1111) | myoB | abolished protein localization to actin wave |
| DBS0266705 | Dd5P1-/ Dd5P2- | Dd5P1 | Dd5P2 | increased chemotaxis to cAMP |
| DBS0266704 | Dd5P1-/ Dd5P3- | Dd5P1 | Dd5P3 | increased chemotaxis to cAMP |
| DBS0266703 | Dd5P2-/ Dd5P3- | Dd5P2 | Dd5P3 | wild type |
| DBS0351414 | Dd5P4-/ [act15]: GFP: Dd5P4(D319G) | Dd5P4 | increased contractile vacuole size | aberrant contractile vacuole discharge | aberrant protein localization to contractile vacuole |
| DBS0302615 | GFP: phgA(1-274: 283-438)/ phgA- | phgA | aberrant hypotonic response |
| DBS0236084 | GP138A-/ GP138B-/ GP138C-/ GP138D- | cfrA | cfrB | cfrC | cfrD | decreased gene expression |
| DBS0351312 | HSPC300-/ [act15]: abpB(129-295) | abpB | hspc300 | aberrant cellular process |
| DBS0236917 | SA219 | dscA-1 | dscA-2 | dscC-1 | dscC-2 | dscD-1 | dscD-2 | dscE | abolished gene expression |
| SA31 | SA31 | dscA-1 | dscA-2 | dscC-1 | dscC-2 | dscD-1 | dscD-2 | dscE | abolished gene expression | abolished stream development | aberrant microtubule cytoskeleton organization | decreased establishment of cell polarity |
| DBS0350570 | [AS]PARP | DDB_G0286613 | DDB_G0289141 | adprt1A | adprt1B | adprt2 | adprt3 | adprt4 | pARTf | pARTg | decreased cell death | aberrant positive regulation of mitochondrial membrane potential |
| DBS0237228 | [AS]cfrA/ [AS]cfrB | cfrA | cfrB | decreased sexual fusion |
| DBS0351041 | [AS]hspA/ [AS]ndkC-1 | hspA | ndkC-1 | ndkC-2 | wild type |
| DBS0350355 | [AS]proA-/ proB-/ lmpA- | lmpA | proA | proB | abolished sporulation | wild type |
| DBS0351311 | [AS]proA/ abpB(129-295) | abpB | proA | aberrant cellular process |
| DBS0236827 | [AS]proA/ proB- | proA | proB | decreased exocytosis | decreased pinocytosis | aberrant exocytosis | increased actin filament polymerization | development arrests at slug stage | aberrant cytokinesis | decreased cell motility | abolished vegetative growth | decreased secretion of lysosomal enzymes | increased phagocytosis |
| DBS0238036 | [AS]proA/ proB-/ [act15]: proA | proA | proB | wild type |
| DBS0238037 | [AS]proA/ proB-/ [act15]: proB | proA | proB | wild type |
| DBS0238035 | [AS]proA/ proB-/ [unk]: FLAG: proC | proA | proB | proC | wild type |
| DBS0350334 | [AS]proA/ proB-/ scrA- | proA | proB | scrA | decreased exocytosis | decreased pinocytosis | decreased secretion of lysosomal enzymes |
| DBS0302685 | [OE]: sgcA(1-2000)(N1106A): GFP/ gca-/ sgcA- | gcA | sgcA | decreased chemotaxis rate |
| DBS0302683 | [OE]: sgcA(878-2843)(N1106A): GFP/ gca-/ sgcA- | gcA | sgcA | decreased chemotaxis rate |
| DBS0302681 | [OE]: sgcA(878-2843): GFP/ sgcA- | gcA | sgcA | aberrant chemotaxis to cAMP | decreased chemotaxis rate |
| DBS0302682 | [OE]: sgcA(N1106A): GFP/ gca-/ sgcA- | gcA | sgcA | increased lateral pseudopodium formation | aberrant chemotaxis to cAMP | aberrant stream morphology | decreased chemotaxis rate |
| DBS0302684 | [OE]: sgcA: GFP/ gca-/ sgcA- | gcA | sgcA | increased lateral pseudopodium formation | decreased chemotaxis rate |
| DBS0350322 | [act15]: FLAG: hbx4/ [act15]: cadA | cadA | hbx4 | wild type |
| DBS0350441 | [act15]: GFP: talA/ mhcA-/ talA- | mhcA | talA | aberrant protein localization |
| DBS0350986 | [act15]: YFP: myoC(G395A) | myoC | decreased pinocytosis | aberrant mitotic spindle organization | decreased phagocytosis |
| DBS0351059 | [act15]: gshB/ [AS]gpaB | gpaB | gshB | aberrant stream morphology | decreased establishment of cell polarity | decreased sporulation |
| DBS0350397 | [act15]: ifkA(881-1514(K1258G,F1320L)) | ifkA | decreased growth rate | increased protein level |
| DBS0350050 | [act15]: myc: cdk8/ [act15]: FLAG: cycC | cdk8 | cycC | precocious development of tipped mound |
| DBS0351051 | [act15]: myc: talA(2255-2492)/ puf118(677-1036) | puf118 | talA | aberrant chemotaxis to cAMP | abolished protein localization to leading edge |
| DBS0351040 | [act15]: snfA(1-379): GFP/ [AS]ndkC-1 | ndkC-1 | ndkC-2 | snfA | wild type |
| DBS0350911 | [act6]: GFP: cepA/ cepA(183-346) | cepA | increased number of centrosomes |
| DBS0351551 | [act6]: GFP: lmnB(1-712)/ S122A | lmnB | aberrant intermediate filament bundle assembly |
| DBS0350498 | [act6]: GFP: rab2A(N118I) | rab2A | aberrant cell-cell adhesion | aberrant hypotonic response | increased growth rate | precocious development |
| DBS0350499 | [act6]: GFP: rab2A(Q64L) | rab2A | decreased autophagic cell death | aberrant cell-cell adhesion | aberrant sorocarp development | aberrant hypotonic response | increased growth rate | increased phagocytosis |
| DBS0350706 | [cotC]: pkaC/ [spiA]: lacZ | pkaC | spiA | precocious gene expression |
| DBS0350700 | [ecmA]: pkaR(G135E/ G261A)/ [ecmB-frag]: lacZ | pkaR | abolished stalk cell differentiation |
| DBS0350196 | [pkaC]: pkaC/ nsfA(A1854T,T1984A,C2131A,A2398T,T2574A) | nsfA | pkaC | decreased spore cell differentiation |
| DBS0350696 | [pkaC]: pkaC/ srfA- | pkaC | srfA | aberrant spore coat morphology | aberrant gene expression |
| DBS0351463 | [tet]rasD(G12T)/ rigA- | rasD | rigA | wild type |
| DBS0350494 | [tgrB1]: [RNAi]abcB3/ [tgrC1]: GFP | abcB3 | delayed development | decreased cAMP level |
| DBS0350837 | [unk]: rasD(G12T)/ [rasD]: rapA | rapA | rasD | increased number of mound tips | aberrant culmination | decreased prespore cell differentiation | aberrant gene expression | decreased stalk cell differentiation |
| DBS0238439 | [unk]: scrA(97-443): GFP | scrA | aberrant cytokinesis | increased vegetative cell size | decreased chemotaxis to cAMP | aberrant cytoskeleton organization |
| DBS0350056 | [unk]: tubA: GFP/ RNAi]cepG | cepG | tubA | aberrant cytokinesis | aberrant microtubule cytoskeleton organization | aberrant protein localization to nuclear envelope | aberrant centromere complex assembly |
| DBS0351237 | [unk]: tubA: GFP/ [RNAi]cepL | cepL | tubA | decreased growth rate | aberrant cytokinesis | aberrant microtubule cytoskeleton organization | aberrant centromere complex assembly |
| DBS0236539 | abcG2-/ abcG18- | abcG18 | abcG2 | decreased rate of endocytosis | decreased growth rate | abolished vegetative growth |
| DBS0236540 | abcG2-/ abcG18-/ rtoA- | abcG18 | abcG2 | rtoA | decreased growth rate | abolished vegetative growth |
| DBS0351535 | abiA-/ pirA-/ AX2 | abiA | pirA | aberrant macropinocytosis | decreased cell motility | aberrant cell morphology |
| DBS0266689 | abiA-/ scrA- | abiA | scrA | decreased cell motility | decreased vegetative cell size |
| DBS0235456 | abpA-/ abpC- | abpA | abpC | decreased pinocytosis | decreased phagocytosis | decreased growth rate | decreased cell motility | aberrant sorocarp development | aberrant cell-cell adhesion | aberrant hyperosmotic response |
| DBS0351087 | abpB-/ abpA- | abpA | abpB | decreased pinocytosis | decreased growth rate | increased cell-cell adhesion | decreased vegetative cell size | aberrant fruiting body morphogenesis | aberrant hyperosmotic response | precocious gene expression | decreased chemotaxis to cAMP |
| DBS0351088 | abpB-/ abpC- | abpB | abpC | decreased prespore gene expression | decreased prestalk gene expression | aberrant fruiting body morphogenesis | aberrant hyperosmotic response | decreased chemotaxis to cAMP |
| DBS0235425 | abpB-/ fimA- | abpB | fimA | decreased vegetative cell size | decreased fruiting body size | decreased sporulation |
| DBS0350938 | abpC-/ [act15]: abpC | abpC | wild type |
| DBS0351553 | abpC-/ [act15]: qkgA(425-1553) | abpC | qkgA-1 | qkgA-2 | aberrant actin filament polymerization |
| DBS0350720 | acaA-/ [acaA-agg]: acaA: myc | acaA | decreased gene expression | decreased fruiting body size |
| DBS0350721 | acaA-/ [acaA-psp]: acaA: myc | acaA | decreased gene expression | decreased mound size | decreased fruiting body size |
| DBS0350722 | acaA-/ [acaA-pst]: acaA: myc | acaA | wild type |
| DBS0350702 | acaA-/ [act15]: HA: pkaC | acaA | pkaC | wild type | delayed development | decreased cAMP level |
| DBS0350725 | acaA-/ [act15]: HA: pkaC/ acrA- | acaA | acrA | pkaC | decreased gene expression | abolished adenylate cyclase activity | development arrests at tipped mound stage |
| DBS0350737 | acaA-/ [act15]: acaA | acaA | aberrant slug development |
| DBS0350738 | acaA-/ [act15]: acaA(1-390;398-1407) | acaA | abolished aggregation |
| DBS0350739 | acaA-/ [act15]: acaA(L394T/ K482N) | acaA | wild type |
| DBS0350603 | acaA-/ [act15]: cap: GFP | acaA | cap | development arrests at loose mound stage | increased calcium-dependent cell-cell adhesion | wild type |
| DBS0350735 | acaA-/ [act15]: pkaR(G135E/ G261A) | acaA | pkaR | increased cAMP level |
| DBS0350736 | acaA-/ [unk]: acaA(F306L/ S498G,K504E,E593V,I649T) | acaA | decreased gene expression | abolished oscillatory cAMP signaling | decreased cAMP level |
| DBS0350711 | acaA-/ [unk]: acgA | acaA | acgA | aberrant sorocarp development |
| DBS0306126 | acapA-/ acapB- | acapA | acapB | decreased sporulation |
| DBS0350194 | acbA-/ [act15]: acbA(Y72A) | acbA | abolished spore cell differentiation |
| AK1211 | acbA-/ tagA- | acbA | tagA | increased prestalk B cell differentiation |
| DBS0350724 | acrA-/ [pkaC]: pkaC | acrA | pkaC | decreased spore germination | decreased fruiting body size | precocious development | decreased sporulation |
| DBS0351190 | adcC-/ [act15]: adcC(1-485) | adcC | decreased protein localization to plasma membrane |
| DBS0351189 | adcC-/ [act15]: adcC(101-654): GFP | adcC | abolished protein localization to plasma membrane |
| DBS0350445 | adcC-/ adcB- | adcB | adcC | increased oscillatory cAMP signaling | aberrant endocytosis | delayed aggregation | aberrant regulation of protein kinase activity |
| DBS0350541 | adprt1A-/ adprt2- | adprt1A | adprt2 | decreased resistance to phleomycin | decreased double-strand break repair via nonhomologous end joining | decreased resistance to cisplatin |
| DBS0351603 | agnA-/ agnB- | agnA | agnB | aberrant production of siRNA involved in RNA interference | increased gene expression |
| HW520 | agtA-/ gnt1(1-253/ H104D) | agtA | gnt1 | development arrests at slug stage |
| DBS0349951 | ampA-/ lmbd2B- | ampA | lmbd2B | aberrant chemotaxis |
| DBS0349963 | ampA-/ sma- | ampA | sma | increased chemotaxis to folate | increased cell-substrate adhesion |
| BS165 | amtA-/ amtC- | amtA | amtC | decreased protein localization to nucleus | aberrant slug migration | decreased ammonia level | delayed gene expression |
| BS169 | amtB-/ amtA- | amtA | amtB | decreased ammonia level |
| BS168 | amtB-/ amtC- | amtB | amtC | decreased ammonia level |
| BS163 | amtC-/ dhkC- | amtC | dhkC | aberrant gene expression |
| DBS0236890 | amtC-/ regA- | amtC | regA | precocious sporulation |
| DBS0350299 | aph1-/ ncstn- | aph1 | ncstn | decreased phagocytosis | decreased prespore cell differentiation |
| DBS0350300 | aph1-/ psenA- | aph1 | psenA | aberrant culmination | abolished catalytic activity | decreased prespore cell differentiation |
| DBS0350000 | arpB+/ aprB-/ [act15]: myc: arpB(T235A/ T236A) | arpB | wild type |
| DBS0349998 | arpB+/ aprB-/ [act15]: myc: arpB(Y200F/ T235A/ T236A) | arpB | decreased actin filament polymerization | delayed aggregation | decreased fruiting body size | decreased establishment of cell polarity | decreased chemotaxis to cAMP | delayed gene expression |
| DBS0350206 | arpin-/ [act15]: GFP: arpin | arpin | wild type |
| DBS0266655 | atg1-/ iplA- | atg1 | iplA | decreased necrotic cell death |
| DBS0252632 | atg1-/ pcp- | atg1 | pcp | abolished autophagosome organization |
| DBS0351613 | atg1-/ tsg101- | atg1 | tsg101 | decreased defense response to Gram-positive bacterium |
| DBS0350838 | atg1-/ vmp1- | atg1 | vmp1 | wild type | abolished protein localization to autophagosome |
| DBS0351576 | atg5-/ abpB-/ [dscB]: abpB(D93A/ D95A/ D97A): GFP | abpB | atg5 | aberrant cellular component organization | abolished vegetative growth |
| DBS0351583 | atg5-/ atg12- | atg12 | atg5 | increased cell death | decreased catalytic activity | decreased growth rate | decreased phagocytosis | increased protein modification | decreased macropinocytosis | aberrant fruiting body morphogenesis |
| DBS0351584 | atg5-/ atg12-/ tipD- | atg12 | atg5 | tipD | increased cell death | decreased catalytic activity | decreased growth rate | aberrant phagocytosis | increased protein modification | decreased macropinocytosis | aberrant fruiting body morphogenesis | increased growth rate |
| DBS0351477 | atg7-/ [act15]: YFP: atg7(C563A) | atg7 | aberrant sorus morphology | decreased spore germination | delayed development |
| DBS0351479 | atg7-/ [act15]: pkaC: YFP | atg7 | pkaC | decreased gene expression | decreased sporulation |
| DBS0351224 | atg8a-/ atg8b- | atg8a | atg8b | increased cell death | decreased catalytic activity | decreased growth rate | decreased phagocytosis | increased protein modification | aberrant sorocarp development | aberrant lysosome organization |
| DBS0350535 | atg9-/ [act15]: cdcD(R154C): RFP | atg9 | cdcD | decreased growth rate | decreased phototaxis |
| DBS0351589 | atg9-/ [act15]: cdcD(R154C/ E219K): RFP | atg9 | cdcD | wild type |
| DBS0350534 | atg9-/ [act15]: cdcD: RFP | atg9 | cdcD | decreased growth rate | aberrant fruiting body morphogenesis | abolished phototaxis |
| DBS0351480 | atg9-/ [act15]: pkaC: YFP | atg9 | pkaC | abolished sporulation |
| DBS0350731 | atg9-/ tipD- | atg9 | tipD | decreased pinocytosis | aberrant phagosome maturation | development arrests at tipped mound stage |
| DBS0351266 | carA-/ [act15]: gpbA: YFP | carA-1 | carA-2 | gpbA | abolished aggregation |
| DBS0350431 | carA-/ [unk]: carA(261-359;S299A,S302G,S303G,S304G,S308A,S324G,S325A,S331A)(369-392;S383A,S385A): eYFP | carA-1 | carA-2 | aberrant adaptation of signaling pathway | aberrant protein localization to plasma membrane |
| RI9 | carA-/ carC- | carA-1 | carA-2 | carC | decreased gene expression | abolished protein localization to plasma membrane |
| RI4 | carA-/ carC- | carA-1 | carA-2 | carC | decreased actin filament polymerization | abolished activation of GTPase activity | abolished aggregation | abolished cGMP-mediated signaling | abolished chemotaxis to cAMP |
| DBS0350568 | carA-/ carC-/ [act15]: carA(261-359;S299A,S302G,S303G,S304G,S308A,S324G,S325A,S331A)(369-392;S383A,S385A) | carA-1 | carA-2 | carC | abolished stream development | aberrant activation of adenylate cyclase activity | aberrant chemotaxis to cAMP | aberrant oscillatory cAMP signaling | aberrant actin filament polymerization |
| DBS0235570 | carB- | carB | development arrests at mound stage |
| DBS0350528 | chdC-/ [ecmA]: lacZ | chdC | decreased prestalk cell differentiation |
| DBS0350527 | chdC-/ [pspA]: lacZ | chdC | decreased prespore cell differentiation |
| DBS0351521 | corA-/ [act15]: FLAG: corA(1-432) | corA | abolished aggregation |
| DBS0350851 | corA-/ aip1- | aip1 | corA | aberrant endocytosis | aberrant cytokinesis | increased actin filament polymerization | development arrests at mound stage | decreased growth rate | aberrant nucleus morphology | increased vegetative cell size | increased protein level | decreased chemotaxis to cAMP |
| DBS0351412 | corA-/ mhcA- | corA | mhcA | aberrant cytokinesis |
| DBS0351413 | corA-/ piaA- | corA | piaA | aberrant cytokinesis |
| TL53 | cotA-/ cotB- | cotA | cotB | aberrant spore coat morphology |
| TL56 | cotA-/ cotB-/ cotC- | cotA | cotB | cotC | decreased spore germination | aberrant spore coat morphology | abolished cellulose binding |
| TL57 | cotA-/ cotB-/ cotC- | cotA | cotB | cotC | aberrant spore coat morphology |
| TL54 | cotB-/ cotC- | cotB | cotC | aberrant spore coat morphology |
| HG1772 | crtA-/ cnxA- | cnxA | crtA | decreased calcium ion import | decreased growth rate | delayed response to cAMP | decreased phagocytosis | aberrant calcium-mediated signaling |
| TL73 | csaA-/ csbA-/ csbC-/ csbC- | csaA | csbA | csbB | csbC | increased stalk width | aberrant late culminant morphology |
| TL122 | csaA-/ tgrC1- | csaA | tgrC1 | abolished calcium-independent cell-cell adhesion |
| TL72 | csbA-/ csbB-/ csbC- | csbA | csbB | csbC | increased resistance to cisplatin | aberrant cytokinesis | aberrant late culminant morphology |
| DBS0304928 | ctnnA-/ mhcA- | ctnnA | mhcA | aberrant cytokinesis |
| DBS0237568 | ctxA-/ [RNAi]enlA | ctxA | enlA | wild type |
| DBS0235599 | ctxA-/ ctxB- | ctxA | ctxB | abolished stream development | aberrant cellular response to fluid shear stress | abolished adenylate cyclase activity | increased lateral pseudopodium formation | aberrant cytokinesis | development arrests at mound stage | aberrant chemotaxis to cAMP | decreased cell motility | aberrant regulation of GTPase activity | aberrant cell morphology | abolished aggregation | aberrant regulation of protein kinase activity | increased bleb assembly |
| DBS0350293 | ctxA-/ ctxB-/ [act15]: GFP: arcA | arcA | ctxA | ctxB | aberrant protein localization to cell cortex |
| DBS0349972 | ctxA-/ ctxB-/ [act15]: acaA: YFP | acaA | ctxA | ctxB | aberrant fruiting body morphogenesis |
| DBS0349973 | ctxA-/ ctxB-/ [act15]: carA: YFP | carA-1 | carA-2 | ctxA | ctxB | abolished stream development | abolished adenylate cyclase activity | development arrests at tight mound stage |
| DBS0266760 | culB-/ pkaR- | culB | pkaR | abolished sporulation | precocious prestalk gene expression | abolished aggregation | abolished prespore gene expression |
| DBS0349807 | detA-/ [act6]: GFP: detA | detA | wild type |
| DBS0349816 | detA-/ [act6]: GFP: detA/ [act6]: 3xHA: culD | culD | detA | increased gene expression |
| DBS0349817 | detA-/ [act6]: GFP: detA/ [act6]: 3xHA: repE | detA | repE | increased gene expression |
| DBS0350393 | dgat1-/ dgat2- | dgat1 | dgat2 | abolished lipid droplet formation | decreased growth rate | increased sporulation | aberrant endoplasmic reticulum membrane organization |
| DBS0349917 | dgcA-/ [act15]: dgcA(1-124): YFP | dgcA | development arrests at slug stage |
| DBS0349918 | dgcA-/ [act15]: dgcA(1-273): YFP | dgcA | development arrests at slug stage |
| DBS0349916 | dgcA-/ [act15]: dgcA(350-521): YFP | dgcA | development arrests at slug stage |
| DBS0350665 | dhkA-/ [act15]: dhkA(D2076N) | dhkA | decreased sporulation |
| DBS0350664 | dhkA-/ [act15]: dhkA(H1396Q) | dhkA | decreased sporulation |
| DBS0350666 | dhkA-/ [act15]: dhkA(H2396Q)/ [act15]: dhkA(D2076N) | dhkA | wild type |
| TL134 | dhkA-/ dhkB- | dhkA | dhkB | abolished sporulation | increased stalk length | decreased stalk width |
| HR49 | dhkA-/ fbxA- | dhkA | fbxA | aberrant fruiting body morphogenesis | decreased sporulation | decreased cAMP level |
| HR51 | dhkA-/ fbxA- | dhkA | fbxA | aberrant fruiting body morphogenesis | decreased sporulation |
| HR50 | dhkA-/ fbxA- | dhkA | fbxA | abolished culmination | decreased sporulation |
| DBS0350663 | dhkA-/ pkaR- | dhkA | pkaR | decreased sporulation |
| DBS0350662 | dhkA-/ regA- | dhkA | regA | decreased sporulation |
| DBS0235714 | dhkK-/ regA- | dhkK | regA | precocious development |
| DBS0235899 | dimA-/ dimB- | dimA | dimB | increased migratory slug size | increased standing slug length | aberrant chemotaxis to cAMP | decreased standing slug width |
| DBS0351395 | dlpA-/ dlpB- | dlpA | dlpB | aberrant cytokinesis |
| HM1196 | dmtA-/ stlA- | dmtA | stlB | decreased outer basal disc size | decreased prestalk O cell differentiation |
| DBS0350561 | dnapkcs-/ adprt2- | adprt2 | dnapkcs | decreased resistance to phleomycin | decreased resistance to cisplatin |
| DBS0351060 | dnapkcs-/ exo1- | dnapkcs | exo1 | decreased resistance to phleomycin |
| DBS0350459 | docD-/ docA- | docA | docD | aberrant fruiting body morphogenesis | delayed development | decreased chemotaxis to cAMP |
| HAD205 | dpoA-/ gskA- | dpoA | gskA | aberrant sorocarp development |
| DBS0302608 | dsgg(1-571: 581-733)/ dsgg- | dsgg | aberrant contractile vacuole organization | aberrant cellular localization |
| DBS0302606 | dsgg-/ [OE]: GFP: lvsD | dsgg | lvsD | wild type |
| DBS0302607 | dsgg-/ [OE]: lvsA | dsgg | lvsA | aberrant contractile vacuole organization |
| DBS0302611 | dsgg-/ [OE]: phgA | dsgg | phgA | aberrant contractile vacuole organization |
| DBS0302604 | dsgg-/ lvsA- | dsgg | lvsA | wild type |
| DBS0302605 | dsgg-/ lvsD- | dsgg | lvsD | aberrant contractile vacuole organization |
| DBS0235927 | dstA-/ dstB- | dstA | dstB | wild type |
| DBS0235932 | dstB-/ dstC- | dstB | dstC | wild type |
| DBS0350414 | dydA-/ dydA(1-278: 501-1211) | dydA | decreased protein localization to cell cortex | increased myosin II assembly | increased actin filament polymerization | aberrant chemotaxis to cAMP |
| DBS0350415 | dydA-/ dydA(1-586: 703-1211) | dydA | decreased protein localization to cell cortex | decreased chemotaxis to cAMP |
| DBS0350803 | dymA-/ ehd- | dymA | ehd | aberrant phagosome maturation | decreased protein processing in phagocytic vesicle |
| DBS0350521 | egeA-/ [unk]: pkaC | egeA | pkaC | decreased gene expression | abolished aggregation |
| DBS0350804 | ehd-/ [act15]: dymA: GFP | dymA | ehd | aberrant phagosome maturation | decreased protein processing in phagocytic vesicle |
| DBS0302598 | elmoA-/ [act15]: elmoA(1-903/ 959-977): GFP | elmoA | decreased cell motility | increased phagocytosis |
| DBS0302474 | epnA-/ [act15]: epnA(R65A/ K78A): GFP | epnA | aberrant spore morphology | abolished protein localization to plasma membrane | abolished phosphatidylinositol-4,5-bisphosphate binding | abolished protein localization to clathrin-coated pit | abolished protein phosphorylation |
| DBS0302475 | epnA-/ [act15]: epnA(T107A): GFP | epnA | aberrant spore morphology | abolished protein localization to plasma membrane |
| DBS0350681 | erkA-/ [act15]: gpaE | erkA | gpaE | wild type |
| DBS0350029 | erkA-/ [act15]: mekA: FLAG | erkA | mekA | increased protein localization to cell cortex |
| DBS0351474 | erkA-/ regA- | erkA | regA | decreased mound size | aberrant fruiting body morphogenesis |
| DBS0350682 | erkB-/ [unk]: erkB(P140S) | erkB | abolished sporulation |
| DBS0235949 | erkB-/ regA- | erkB | regA | increased oscillatory cAMP signaling | abolished aggregation |
| HR46 | fbxA-/ regA- | fbxA | regA | aberrant fruiting body morphogenesis | decreased sporulation |
| HR48 | fbxA-/ regA- | fbxA | regA | aberrant fruiting body morphogenesis | decreased sporulation |
| DBS0350129 | fcsB-/ fcsA- | fcsA | fcsB | decreased catalytic activity | decreased growth rate | delayed development |
| DBS0350955 | fhbA-/ fhbB- | fhbA | fhbB | aberrant cellular response to stress |
| HM1351 | fncD2-/ rev3- | fncD2 | rev3 | decreased resistance to cisplatin |
| HM1405 | fncD2-/ xpf- | fncD2 | xpf | decreased resistance to cisplatin |
| DBS0235967 | forA-/ forB- | forA | forB | wild type |
| DBS0351307 | forE-/ forA-/ forH- | forA | forE | forH | aberrant cortical actin cytoskeleton organization | aberrant cytokinesis | aberrant sorocarp development | decreased cell motility | aberrant cell morphology |
| DBS0235978 | fszA-/ fszB- | fszA | fszB | aberrant mitochondrion morphology |
| DBS0350077 | gadA-/ gadB- | gadA | gadB | delayed aggregation |
| DBS0350403 | gapA-/ iqgC- | gapA | iqgC | decreased protein kinase activation | decreased chemotaxis to cAMP |
| DBS0349868 | gbpC-/ [act15]: gbpC(1-2331: 2470-2631): GFP | gbpC | aberrant stream morphology | decreased chemotaxis to cAMP |
| DBS0235996 | gbpC-/ gbpD- | gbpC | gbpD | delayed aggregation | decreased chemotaxis rate | decreased establishment of cell polarity | increased bleb assembly |
| DBS0236000 | gca-/ sgcA- | gcA | sgcA | decreased protein kinase activation |
| DBS0302679 | gca-/ sgcA- | gcA | sgcA | increased lateral pseudopodium formation | aberrant activation of GTPase activity | aberrant chemotaxis to cAMP | aberrant taxis | aberrant stream morphology | decreased mound size | decreased chemotaxis rate | decreased fruiting body size |
| DBS0236095 | gdt1-/ gpaB- | gdt1 | gpaB | increased gene expression | abolished aggregation |
| DBS0236010 | gefB-/ rasS- | gefB | rasS | decreased phagocytosis | increased cell motility |
| DBS0351462 | gefE-/ uduB- | gefE | uduB | wild type |
| DBS0350823 | gefH-/ gefA- | gefA | gefH | decreased actin filament polymerization | aberrant chemotaxis to cAMP | abolished activation of GTPase activity | decreased protein kinase activation | abolished aggregation |
| DBS0350814 | gflB-/ [act15]: GFP: gflB(380-1601,T1180E) | gflB | decreased chemotaxis to cAMP |
| DBS0238605 | gpaA-/ rpkA- | gpaA | rpkA | delayed aggregation | abolished aggregation |
| DBS0351103 | gpaB-/ [act15]: gpaB(C4A) | gpaB | abolished protein localization to plasma membrane | decreased cGMP-mediated signaling | abolished aggregation |
| DBS0351105 | gpaB-/ [act15]: gpaB(G207A) | gpaB | abolished protein localization to plasma membrane |
| DBS0351104 | gpaB-/ [act15]: gpaB(G2A) | gpaB | abolished protein localization to plasma membrane |
| DBS0351217 | gpaB-/ [act15]: gpaI | gpaB | gpaI | wild type |
| DBS0351267 | gpaB-/ [act15]: gpbA: YFP | gpaB | gpbA | abolished aggregation |
| DBS0351214 | gpaB-/ [act15]: rasG(S17N) | gpaB | rasG | abolished activation of GTPase activity |
| DBS0350373 | gpaB-/ regA- | gpaB | regA | decreased number of mounds |
| DBS0350608 | gpaD-/ [act15]: gpaD(Q200L) | gpaD | development arrests at loose mound stage | decreased chemotaxis to folate | decreased protein kinase activation |
| DBS0350607 | gpaD-/ [act15]: gpaD(R107E,R108E) | gpaD | development arrests at slug stage | aberrant slug development |
| DBS0351269 | gpaD-/ [act6]: AEQ | gpaD | aberrant calcium-mediated signaling |
| DBS0350374 | gpaD-/ regA- | gpaD | regA | aberrant aggregation | abolished slug migration | decreased sporulation |
| DBS0350378 | gpaD-/ regA-/ [ecmB]: lacZ | gpaD | regA | increased prestalk O cell differentiation |
| DBS0350678 | gpaE-/ [act15]: gpaE(K10E/ K11E) | gpaE | delayed development of tipped mound | delayed gene expression |
| DBS0350624 | gpaE-/ erkA- | erkA | gpaE | wild type | decreased mound size | precocious development |
| LW17 | gpbA-/ [act15]: carC | carC | gpbA | abolished aggregation |
| DBS0351260 | gpbA-/ [act15]: gpbA(A99T/ Y271H/ C335M) | gpbA | abolished activation of adenylate cyclase activity | aberrant fruiting body morphogenesis |
| DBS0351261 | gpbA-/ [act15]: gpbA(M30V/ K85R/ S104P/ Q163H) | gpbA | development arrests at mound stage | abolished activation of adenylate cyclase activity | decreased chemotaxis to cAMP |
| DBS0351263 | gpbA-/ [act15]: gpbA(M48T/ I52T/ E310G) | gpbA | wild type | decreased activation of adenylate cyclase activity | decreased gene expression | aberrant slug development |
| DBS0351259 | gpbA-/ [act15]: gpbA(N147D/ H149R/ N237S) | gpbA | development arrests at mound stage | abolished activation of adenylate cyclase activity | abolished chemotaxis to cAMP |
| DBS0351264 | gpbA-/ [act15]: gpbA(R13G/ N74S/ S79P/ H149R/ V178A/ V194R/ F293L) | gpbA | decreased activation of adenylate cyclase activity | decreased gene expression | development arrests at tipped mound stage |
| DBS0351262 | gpbA-/ [act15]: gpbA(S196G/ V199D/ C211R) | gpbA | decreased activation of adenylate cyclase activity | aberrant fruiting body morphogenesis |
| DBS0351258 | gpbA-/ [act15]: gpbA(V88A/ F229S/ D235V) | gpbA | abolished activation of adenylate cyclase activity | aberrant fruiting body morphogenesis | decreased chemotaxis to cAMP |
| DBS0351268 | gpbA-/ [act6]: AEQ | gpbA | aberrant calcium-mediated signaling |
| HO547 | gpbA-/ [act6]: FRB: [act15]: RFP: gpbA/ [act15]: cnxA: CFP: FKBP/ [act15]: limE(1-145): GFP | gpbA | aberrant cortical actin cytoskeleton organization |
| DBS0351198 | gpbA-/ [act6]: yakA | gpbA | yakA | abolished vegetative growth |
| DBS0350078 | grlB-/ grlE- | grlB | grlE | decreased small molecule binding | delayed aggregation |
| DBS0350284 | grlJ-/ [act15]: grlJ: GFP | grlJ | wild type |
| DBS0349881 | gskA-/ [act15]: gskA(Y214F) | gskA | abolished stream development |
| DBS0350260 | gskA-/ [unk]: pikA(1-492(S7D/ S11D/ S109D/ S113D/ S177D/ S181D)) | gskA | pikA | wild type |
| DBS0351102 | gskA-/ glkA- | glkA | gskA | aberrant sorocarp development | decreased chemotaxis to cAMP | increased protein kinase activation |
| DBS0350269 | gxcT-/ [act15]: GFP: gxcT | gxcT | wild type |
| DBS0350656 | hatA-/ [hatB]: hatB | hatA | hatB | aberrant cellular response to stress |
| DBS0236131 | hbx2-/ warA- | hbx2 | warA | increased basal disc size | development arrests at mound stage | decreased prespore cell differentiation | increased prestalk O cell differentiation |
| DBS0350880 | hbx9-/ [ecmA]: lacZ | hbx9 | increased prestalk A cell differentiation |
| DBS0350364 | hfnA-/ abpC- | abpC | hfnA | wild type | aberrant prestalk O cell differentiation | decreased phototaxis |
| DBS0305951 | hipA-/ epnA- | epnA | hipA | decreased spore germination | aberrant spore morphology |
| BS161 | ifkA-/ ifkB- | ifkA | ifkB | increased mound size | increased number of mound tips | increased cell-cell adhesion | increased cell-substrate adhesion | aberrant fruiting body morphogenesis |
| DBS0351436 | ireA-/ [act15]: ireA(K603N): GFP | ireA | decreased protein level | aberrant endoplasmic reticulum organization | aberrant cellular response to stress |
| DBS0351437 | ireA-/ [act15]: ireA(N927A): GFP | ireA | decreased protein level | aberrant endoplasmic reticulum organization | aberrant cellular response to stress |
| DBS0350959 | kif10-/ [act15]: dhcA(1384-4725) | dhcA | kif10 | wild type |
| DBS0350042 | kif4-/ [act15]: dhcA(1384-4725) | dhcA | kif4 | aberrant mitotic spindle organization |
| DBS0350947 | kif8-/ [act15]: dhcA(1384-4725) | dhcA | kif8 | wild type |
| DBS0351457 | kil1-/ lrrkA- | drkD | kil1 | aberrant defense response to bacterium |
| DBS0350044 | kil2-/ [act15]: kil1 | kil1 | kil2 | abolished defense response to bacterium |
| DBS0351458 | kil2-/ lrrkA- | drkD | kil2 | aberrant defense response to bacterium |
| DBS0350875 | kil2-/ vps13F- | kil2 | vps13F | aberrant defense response to bacterium | decreased growth rate |
| DBS0350600 | krsB-/ krsA- | krsA | krsB | aberrant stream morphology | delayed development |
| DBS0350536 | ku80-/ dclre1- | dclre1 | ku80 | wild type |
| DBS0236729 | limB-/ paxB- | limB | paxB | development arrests at mound stage |
| DBS0350565 | limD1-/ limC- | limC | limD1 | delayed aggregation | aberrant cytokinesis | abolished vegetative growth | aberrant response to osmotic stress | decreased chemotaxis to cAMP | aberrant actin filament organization | decreased establishment of cell polarity |
| DBS0350453 | lpten-/ [act15]: lpten: RFP | lpten | wild type |
| DBS0350114 | lst8-/ [act15]: GFP: rheb(Q64L) | lst8 | rheb | increased phagocytosis |
| DBS0350030 | mekA-/ [act15]: Myc: erkA | erkA | mekA | abolished protein localization to cell cortex |
| DBS0238098 | mekA-/ ppp4C- | mekA | ppp4c | decreased mound size |
| DBS0238109 | mekA-/ ppp4C-/ [act15]: FLAG: pppC | ppp4c | decreased mound size | precocious development |
| DBS0236542 | mekA-/ smkA- | mekA | smkA | decreased mound size |
| DBS0237564 | mhcA-/ [act15]: GFP: ctxA/ [RNAi]enlA | ctxA | enlA | mhcA | aberrant mitotic actomyosin contractile ring contraction |
| DBS0350489 | mhcA-/ [act15]: GFP: mhcA/ [RNAi]rmd1 | mhcA | rmd1 | abolished protein localization to cleavage furrow |
| DBS0350808 | mhcA-/ [act15]: mhcA(1-933: 1455-2116] | mhcA | wild type | aberrant cytokinesis | aberrant fruiting body morphogenesis |
| DBS0350668 | mhcA-/ forA- | forA | mhcA | abolished cell motility | decreased cell motility |
| DBS0351411 | mhcA-/ piaA- | mhcA | piaA | aberrant cytokinesis |
| CW0431 | mhkA-/ mhkB-/ mhkC- | mhkA | mhkB | mhkC | increased myosin II assembly | decreased growth rate | aberrant cytokinesis | aberrant chemotaxis | decreased cell motility |
| DBS0236556 | mhkA-/ mhkC- | mhkA | mhkC | increased myosin II assembly | decreased growth rate | aberrant cytokinesis |
| CW0394 | mhkA/ mhkB | mhkA | mhkB | increased myosin II assembly | decreased growth rate | aberrant cytokinesis |
| DBS0350123 | midA-/ [act15]: GFP: atg18 | atg18 | midA | increased number of autophagosomes |
| DBS0350136 | midA-/ [act15]: GFP: tkt | midA | tkt-1 | tkt-2 | increased autophagy |
| DBS0351180 | midA/ [act15]: midA(E200A) | midA | aberrant cellular homeostasis | decreased growth rate | decreased phototaxis |
| DBS0351182 | midA/ [act15]: midA(G170V/ G172V) | midA | aberrant cellular homeostasis | decreased growth rate | decreased phototaxis |
| DBS0351181 | midA/ [act15]: midA(N205A) | midA | aberrant cellular homeostasis | decreased growth rate | decreased phototaxis |
| DBS0350027 | mip1-/ [act15]: mekA: FLAG | mekA | mip1-1 | mip1-2 | aberrant protein localization to cytoplasm |
| DBS0309109 | mipp1-/ dpoA- | dpoA | mipp1 | aberrant inositol phosphate metabolic process | increased response to lithium |
| DBS0236561 | mkcA-/ tagB- | mkcA | tagB | decreased sporulation |
| DBS0236562 | mkcA-/ tagC- | mkcA | tagC | decreased sporulation |
| DBS0351550 | mlcR-/ [ecmAO]: GFP | mlcR | aberrant development of tipped mound |
| DBS0349988 | mrfA-/ dimB-/ [emcA]: lacZ | dimB | mrfA | decreased prestalk A cell differentiation |
| DBS0304881 | mrps4- | mrps4 | delayed aggregation |
| DBS0351541 | mscS-/ mclN-/ pkd2- | mcln | mscS | pkd2 | aberrant calcium-mediated signaling |
| DBS0304882 | mtDNA- | DidioMp05 | DidioMp21 | DidioMp26 | DidioMp27 | DidioMp30 | DidioMp35 | DidioMp36 | ai2a | ai2b | ai3 | ai4 | atp1 | atp4 | atp6 | atp8 | atp9 | cox1/ 2 | cox3 | cytB | mrpl11 | mrpl14 | mrpl16 | mrpl2 | mrpl6 | mrps12 | mrps13 | mrps14 | mrps19 | mrps2 | mrps4 | mrps7 | mrps8 | nad1 | nad11 | nad2 | nad3 | nad4 | nad4L | nad5 | nad6 | nad7 | nad9 | rnlA | abolished vegetative growth | abolished aggregation |
| DBS0351489 | mvpA-/ mvpB- | mvpA | mvpB | decreased growth rate | aberrant cellular component organization |
| HDT5 | myoA-/ myoB- | myoA | myoB | decreased pinocytosis | increased secretion of lysosomal enzymes | increased filopodium formation | aberrant aggregation | aberrant endosomal transport | decreased defense response to Gram-negative bacterium | aberrant cortical actin cytoskeleton organization | increased lateral pseudopodium formation | decreased growth rate | delayed aggregation | decreased cell motility | decreased fruiting body size | aberrant actin filament organization | decreased chemotaxis to cAMP | aberrant cytoskeleton organization |
| DBS0350990 | myoA-/ myoB-/ [act15]: myoB | myoA | myoB | delayed aggregation |
| DBS0350991 | myoA-/ myoB-/ [act15]: myoB(1-1057) | myoA | myoB | decreased pinocytosis | decreased growth rate | aberrant actin filament organization |
| DBS0350992 | myoA-/ myoB-/ [act15]: myoB(S332) | myoA | myoB | decreased pinocytosis | decreased growth rate | aberrant actin filament organization |
| DBS0351038 | myoA-/ myoF- | myoA | myoF | decreased lateral pseudopodium retraction | decreased cell motility | decreased chemotaxis to cAMP | aberrant cell morphology | abolished aggregation |
| DBS0351378 | myoB-/ [act15]: GFP: myoB(1-720) | myoB | abolished protein localization to plasma membrane |
| DBS0351379 | myoB-/ [act15]: GFP: myoB(1-800,813-1111) | myoB | abolished protein localization to actin wave | abolished protein localization to plasma membrane |
| DBS0351380 | myoB-/ [act15]: GFP: myoB(713-1111) | myoB | abolished protein localization to leading edge |
| DBS0351367 | myoB-/ [act15]: myoB(S332A) | myoB | abolished protein phosphorylation |
| HDT6 | myoB-/ myoC- | myoB | myoC | increased secretion of lysosomal enzymes | decreased pinocytosis | increased filopodium formation | decreased growth rate | decreased cell motility | decreased fruiting body size | aberrant actin filament organization | aberrant cytoskeleton organization |
| DBS0351031 | myoD-/ myoE- | myoD | myoE | decreased fruiting body size |
| DBS0351034 | myoD-/ myoE-/ myoF- | myoD | myoE | myoF | decreased actin filament polymerization | aberrant engulfment during phagocytosis | decreased chemotaxis to cAMP | decreased fruiting body size |
| DBS0351033 | myoD-/ myoF- | myoD | myoF | decreased fruiting body size |
| DBS0351032 | myoE-/ myoF- | myoE | myoF | decreased fruiting body size |
| DBS0351400 | myoI-/ [act15]: GFP: myoI(1-1020) | myoI | abolished protein localization to pseudopodium | decreased filopodium formation |
| DBS0351398 | myoI-/ [act15]: GFP: myoI(2057-2357) | myoI | increased filopodium formation |
| DBS0351399 | myoI-/ [act15]: GFP: myoI(K23333A,K2336A) | myoI | increased filopodium formation |
| SB14 | napA-/ pirA- | napA | pirA | decreased actin filament polymerization |
| DBS0350301 | ncstn-/ psenA- | ncstn | psenA | aberrant culmination | decreased prespore cell differentiation |
| DBS0350125 | ndufaf5--/ [act15]: ndufaf5(G86V): GFP: TAP | ndufaf5 | decreased growth rate |
| DBS0350126 | ndufaf5--/ [act15]: ndufaf5(L165F): GFP: TAP | ndufaf5 | decreased growth rate |
| DBS0350127 | ndufaf5--/ [act15]: ndufaf5(L235P): GFP: TAP | ndufaf5 | decreased growth rate |
| DBS0350122 | ndufaf5-/ [act15]: GFP: atg18 | atg18 | ndufaf5 | increased number of autophagosomes |
| DBS0350134 | ndufaf5-/ [act15]: GFP: tkt | ndufaf5 | tkt-1 | tkt-2 | increased autophagy |
| DBS0304634 | nfaA-/ rasG- | nfaA | rasG | decreased establishment of cell polarity |
| DBS0350003 | nhe1-/ [act15]: GFP: aip1 | aip1 | nhe1 | decreased establishment of cell polarity | decreased chemotaxis to cAMP |
| DBS0350006 | nhe1-/ [act15]: GFP: aip1(E125A, E167A, F181A, F193A) | aip1 | nhe1 | abolished aggregation | abolished chemotaxis to cAMP |
| DBS0350001 | nhe1-/ [act15]: aip1(168-597) | aip1 | nhe1 | delayed development |
| DBS0350002 | nhe1-/ [act15]: aip1(383-597): FLAG | aip1 | nhe1 | decreased actin filament polymerization | abolished establishment of cell polarity | abolished chemotaxis to cAMP |
| DBS0350509 | nlp-/ slp- | nlp | slp | decreased actin filament polymerization | aberrant organelle organization | abolished protein localization to cytoplasmic vesicle | decreased chemotaxis to cAMP |
| DBS0236941 | nosA-/ sonA- | nosA | sonA | wild type |
| DBS0236610 | noxA-/ noxB | noxA | noxB | abolished sporulation | aberrant sorocarp development | decreased superoxide generation |
| DBS0350768 | noxA-/ noxB-/ noxC- | noxA | noxB | noxC | aberrant defense response to bacterium |
| DBS0350093 | nrampB-/ nramp1- | nramp1 | nrampB | increased number of tip-organizers | decreased defense response to Gram-negative bacterium | delayed aggregation |
| DBS0306169 | p2xA-/ p2xB-/ p2xC-/ p2xD-/ p2xE- | p2xA | p2xB | p2xC | p2xD | p2xE | delayed hypotonic response | decreased growth rate |
| DBS0350430 | pakB-/ [act15]: RFP: abpE/ [act15]: GFP: pak(1-180) | abpE-1 | abpE-2 | pakB | wild type |
| DBS0236715 | pakB-/ pakC- | pakB | pakC | decreased chemotaxis rate |
| DBS0350973 | paxB-/ [act15]: gpaH | gpaH | paxB | aberrant cytokinesis |
| DBS0304929 | paxB-/ mhcA- | mhcA | paxB | aberrant cytokinesis |
| DBS0235992 | pdeD-/ pdeE- | pdeD | pdeE | decreased protein localization to cell cortex | decreased 3',5'-cyclic-GMP phosphodiesterase activity | decreased 3',5'-cyclic-AMP phosphodiesterase activity | decreased lateral pseudopodium formation | increased protein kinase activation |
| DBS0350893 | pdeD-/ pdeE-/ [unk]: pdeE | pdeD | pdeE | delayed aggregation |
| DBS0350799 | pdkA-/ pdkB- | pdkA | pdkB | aberrant chemotaxis to cAMP | development arrests at mound stage | decreased protein kinase activation | decreased establishment of cell polarity |
| DBS0350819 | pdkA-/ pdkB- | pdkA | pdkB | aberrant sorocarp development |
| DBS0236742 | pefA-/ pefB- | pefA | pefB | wild type |
| DBS0236745 | pefB-/ cybA- | cybA | pefB | wild type |
| DBS0236746 | pefB-/ noxA- | noxA | pefB | wild type |
| DBS0236747 | pefB-/ noxA-/ [act15]: pefB | noxA | pefB | aberrant sorocarp development |
| DBS0236748 | pefB-/ noxB- | noxB | pefB | wild type |
| DBS0236749 | pefB-/ noxC- | noxC | pefB | abolished sporulation | aberrant sorocarp development |
| DBS0305024 | pgtB-/ pgtC- | pgtB | pgtC | aberrant cellular metabolic process | aberrant spore coat morphology | aberrant hyperosmotic response |
| DBS0304869 | phg1A-/ [act15]: phg1A(1-276): phg1B221-587) | phg1A | phg1B | decreased phagocytosis |
| DBS0304868 | phg1A-/ [act15]: phg1B | phg1A | phg1B | increased secretion of lysosomal enzymes | wild type | decreased cell-substrate adhesion | aberrant protein level | decreased phagocytosis |
| DBS0304870 | phg1A-/ [act15]: phg1B(1-220): phg1a(277-642) | phg1A | phg1B | decreased phagocytosis |
| DBS0304872 | phg1A-/ phg1B- | phg1A | phg1B | increased secretion of lysosomal enzymes | decreased cell-substrate adhesion | decreased phagocytosis | decreased growth rate | development arrests at tipped mound stage | abolished culmination |
| DBS0302610 | phgA-/ [OE]: dsgg | dsgg | phgA | aberrant contractile vacuole organization |
| DBS0351455 | piaA(G917D)/ [unk]: GFP: piaA(G963E) | piaA | abolished aggregation |
| DBS0350882 | piaA(G917D)/ acrA- | acrA | piaA | abolished gene expression | abolished establishment of cell polarity | abolished chemotaxis to cAMP |
| DBS0350877 | piaA(G917D)/ hephA- | hephA | piaA | increased response to cAMP | wild type | abolished activation of adenylate cyclase activity | decreased cAMP level |
| DBS0236766 | pikA-/ pikB- | pikA | pikB | aberrant negative chemotaxis | decreased response to bacterium | decreased actin filament polymerization | decreased activation of GTPase activity | abolished protein localization to plasma membrane | aberrant chemotaxis to cAMP | decreased cell motility | abolished protein kinase activation | abolished protein localization to trailing edge | decreased chemotaxis to folate | decreased chemotaxis to cAMP | decreased myosin II assembly |
| DBS0236773 | pikA-/ pikB- | pikA | pikB | abolished stream development | decreased pinocytosis | aberrant aggregation | decreased exocytosis | aberrant activation of adenylate cyclase activity | aberrant macropinocytosis | abolished protein localization to plasma membrane | delayed aggregation | decreased spore cell differentiation | increased cAMP level | abolished vegetative growth | aberrant sorocarp development | aberrant phagolysosome formation | aberrant phagosome maturation | decreased phosphatidylinositol biosynthesis | aberrant fruiting body morphogenesis | aberrant actin filament organization | aberrant cell morphology |
| HM1141 | pikA-/ pikB- | pikA | pikB | decreased pinocytosis | decreased growth rate | decreased cell motility | decreased taxis |
| DBS0350471 | pikA-/ pikB-/ [act15]: GFP: cap | cap | pikA | pikB | wild type |
| DBS0252703 | pikA-/ pikB-/ pikC- | pikA | pikB | pikC | decreased protein localization to leading edge | increased cell motility |
| HM1200 | pikA-/ pikB-/ pikC-/ pikF-/ pikG- | pikA | pikB | pikC | pikF | pikG | aberrant aggregation | decreased pinocytosis | decreased protein tyrosine phosphorylation | increased chemotaxis to folate | aberrant macropinocytosis | decreased growth rate | decreased phagocytosis | decreased cell motility | increased bleb assembly | decreased chemotaxis to cAMP | aberrant protein localization to plasma membrane | aberrant signal transduction |
| HM1284 | pikA-/ pikB-/ pikC-/ pikF-/ pikG-/ pikH- | pikA | pikB | pikC | pikF | pikG | pikH | decreased defense response to Gram-negative bacterium | decreased cell motility |
| HM1295 | pikA-/ pikB-/ pikC-/ pikF-/ pikG-/ pten- | pikA | pikB | pikC | pikF | pikG | pten | aberrant aggregation | decreased defense response to Gram-negative bacterium | decreased growth rate | decreased cell motility | increased resistance to N-Phenylthiourea |
| DBS0238073 | pikA-/ pikB-/ plaA- | pikA | pikB | plaA | decreased actin filament polymerization | delayed aggregation | aberrant chemotaxis to cAMP | abolished positive chemotaxis |
| DBS0350828 | pinA-/ [ecmAO]: lacZ | pinA | aberrant prestalk cell differentiation |
| DBS0350827 | pinA-/ [pspA]: lacZ | pinA | aberrant prespore cell differentiation |
| DBS0351206 | pirA-/ pirA(K193D/ R194D): EGFP | pirA | abolished protein localization to cell periphery | decreased protein phosphorylation |
| DBS0350708 | pkaC-/ [act6]: pkaC(303-648) | pkaC | wild type |
| DBS0350707 | pkaC-/ [act6]: pkaC(330-648) | pkaC | abolished aggregation |
| DBS0350710 | pkaC-/ [dscC]: LUC | pkaC | decreased gene expression | increased macropinocytosis |
| DBS0236782 | pkaC-/ gdt1- | gdt1 | pkaC | increased gene expression | abolished aggregation |
| DBS0350113 | pkbA-/ [act15]: GFP: rheb(Q64L) | pkbA | rheb | decreased phagocytosis |
| DBS0236785 | pkbA-/ pkgB- | pkbA | pkgB | aberrant chemotaxis to cAMP | abolished vegetative growth | decreased chemotaxis rate | abolished protein phosphorylation | abolished aggregation | aberrant cellular response to extracellular stimulus | increased activation of GTPase activity | increased protein kinase activation |
| DBS0304640 | pkbA-/ pkgB- | pkbA | pkgB | aberrant cell motility | abolished vegetative growth |
| DBS0351317 | pkbA-/ pkgB- | pkbA | pkgB | aberrant macropinocytosis | abolished vegetative growth | abolished macropinocytosis |
| DBS0350919 | pkcA-/ [act15]: pldB | pkcA | pldB | aberrant aggregation | decreased sporulation |
| DBS0350917 | pkcA-/ [ecmA]: GFP | pkcA | aberrant prestalk gene expression |
| DBS0351542 | pkd2-/ iplA- | iplA | pkd2 | aberrant calcium-mediated signaling |
| DBS0350831 | plaA-/ piaA- | piaA | plaA | decreased taxis | decreased chemotaxis to cAMP | aberrant actin filament organization |
| DBS0350486 | plaA-/ sgcA- | plaA | sgcA | aberrant chemotaxis to cAMP |
| DBS0350487 | plaA-/ sgcA-/ pkgB- | pkgB | plaA | sgcA | aberrant chemotaxis to cAMP |
| DBS0351356 | ppk1-/ [act15]: GFP: hsp48 | hsp48 | ppk1 | decreased protein level |
| DBS0350304 | psenA-/ psenB- | psenA | psenB | increased gene expression | abolished prespore cell differentiation | development arrests at mound stage | increased protein modification | decreased phagocytosis | aberrant calcium-mediated signaling | increased cAMP level | aberrant sorocarp development | decreased macropinocytosis | aberrant phagosome maturation | decreased protein processing in phagocytic vesicle | decreased prestalk gene expression | decreased stalk cell differentiation |
| DBS0350305 | psenA-/ psenB-/ [act15]: GFP: psenB | psenA | psenB | wild type |
| DBS0350306 | psenA-/ psenB-/ [act15]: psenB(D348A/ D394A) | psenA | psenB | wild type |
| DBS0350298 | psenB-/ psenA- | psenA | psenB | aberrant culmination | decreased phagocytosis | abolished catalytic activity | decreased prespore cell differentiation |
| DBS0350829 | psrA-/ [unk]: FLAG: rasD(G12T) | psrA | rasD | increased protein kinase activation |
| DBS0350454 | pten-/ [act15]: lpten: RFP | lpten | pten | wild type |
| DBS0350754 | pten-/ [act15]: pten(186-515): GFP | pten | aberrant sorocarp development | decreased chemotaxis to cAMP |
| DBS0350755 | pten-/ [act15]: pten(C124S): GFP | pten | aberrant sorocarp development | decreased chemotaxis to cAMP |
| DBS0351587 | pten-/ [act15]: pten(G129E) | pten | increased lateral pseudopodium formation | aberrant localization |
| DBS0349888 | pten-/ gefS- | gefS | pten | aberrant cytokinesis | decreased chemotaxis to cAMP |
| DBS0349891 | pten-/ pakA- | pakA | pten | decreased chemotaxis to cAMP |
| DBS0349893 | pten-/ pakA-/ [act15]: pakA(T585A): GFP | pakA | pten | decreased chemotaxis to cAMP |
| DBS0349900 | pten-/ pakA-/ [act15]: pakA(T585E): GFP | pakA | pten | aberrant cytokinesis | decreased chemotaxis to cAMP |
| DBS0349899 | pten-/ pakA-/ [act15]: pakA: GFP | pakA | pten | aberrant cytokinesis |
| DBS0349887 | pten-/ piaA- | piaA | pten | decreased protein kinase activity | decreased chemotaxis to cAMP |
| DBS0349880 | pten-/ pkbA- | pkbA | pten | decreased chemotaxis to cAMP |
| DBS0349886 | pten-/ pkgB- | pkgB | pten | aberrant cytokinesis | increased protein kinase activation |
| DBS0350675 | ptpB-/ [act15]: 6xHis: erkA | erkA | ptpB | aberrant stream morphology |
| DBS0350579 | pyk3-/ phg2- | phg2 | pyk3 | abolished gene expression | decreased protein phosphorylation | aberrant protein localization to nucleus |
| DBS0351348 | racE-/ [act15]: GFP: racE(G20V) | racE | decreased protein phosphorylation | decreased chemotaxis to cAMP |
| DBS0351349 | racE-/ [act15]: GFP: racE(G23V) | racE | increased protein phosphorylation |
| DBS0351350 | racE-/ [act15]: GFP: racE(S192D) | racE | increased protein phosphorylation | wild type |
| DBS0351347 | racE-/ [act15]: GFP: racE(T25N) | racE | wild type |
| DBS0351614 | racE-/ [act15]: GFP: racE(T25N/ S192D) | racE | wild type |
| DBS0351351 | racE-/ [act15]: GFP: rasC(Q62L) | racE | rasC | decreased protein phosphorylation |
| DBS0349949 | racE-/ [act15]: fttB | fttB | racE | decreased growth rate |
| DBS0349946 | racE-/ [act15]: fttB: GFP | fttB | racE | abolished protein localization to cell cortex |
| DBS0350956 | racE-/ [act15]racE(G20V) | racE | wild type |
| DBS0350957 | racE-/ [act15]racE(T25N) | racE | abolished cytokinesis |
| DBS0350631 | rapgapB-/ [ecmA]: lacZ | rapgapB | aberrant cell migration to prestalk region |
| DBS0350632 | rapgapB-/ [ecmO]: lacZ | rapgapB | aberrant cell migration to prestalk region |
| DBS0350740 | rasC-/ [rasC]: rasG | rasC | rasG | abolished activation of adenylate cyclase activity | abolished aggregation |
| DBS0350742 | rasC-/ [rasC]: rasG(1-77(D30A)): rasC(79-189) | rasC | rasG | wild type |
| DBS0350741 | rasC-/ [rasC]: rasG(D30A) | rasC | rasG | aberrant aggregation | decreased activation of adenylate cyclase activity |
| DBS0236855 | rasC-/ dmpA- | dmpA | rasC | abolished stream development |
| DBS0236857 | rasC-/ rasD- | rasC | rasD | abolished aggregation |
| DBS0236858 | rasC-/ rasG- | rasC | rasG | aberrant cell separation during cytokinesis | wild type | aberrant cell motility | decreased activation of adenylate cyclase activity | decreased gene expression | abolished guanylyl cyclase activity | abolished chemotaxis to folate | decreased growth rate | aberrant chemotaxis to folate | abolished protein kinase activation | abolished vegetative growth | decreased cell motility | increased protein level | abolished aggregation | delayed gene expression | abolished chemotaxis to cAMP | abolished positive regulation of chemorepellant activity |
| DBS0266697 | rasC-/ rasG-/ [act15]: carA | carA-1 | carA-2 | rasC | rasG | decreased activation of adenylate cyclase activity | abolished activation of GTPase activity | decreased growth rate | abolished vegetative growth | abolished protein kinase activation | abolished cGMP-mediated signaling | abolished chemotaxis to cAMP |
| DBS0350480 | rasC-/ rasG-/ [rasG]: rasD | rasC | rasD | rasG | decreased chemotaxis to folate |
| DBS0350482 | rasC-/ rasG-/ [rasG]: rasD(1-104): rasG(103-189) | rasC | rasD | rasG | decreased chemotaxis to folate |
| DBS0350481 | rasC-/ rasG-/ [rasG]: rasG | rasC | rasG | wild type |
| DBS0350483 | rasC-/ rasG-/ [rasG]: rasG(1-104): rasD(103-187) | rasC | rasD | rasG | wild type |
| DBS0351062 | rasC-/ rasG-/ [unk]: carA | carA-1 | carA-2 | rasC | rasG | decreased protein localization to plasma membrane |
| DBS0351449 | rasC-/ rasS- | rasC | rasS | increased macropinocytosis |
| DBS0351213 | rasC-[act15]: rasG(S17N) | rasC | rasG | abolished activation of GTPase activity | decreased chemotaxis to cAMP |
| DBS0236864 | rasG-/ [OE]: rasB | rasB | rasG | decreased growth rate |
| DBS0351447 | rasG-/ rasS- | rasG | rasS | decreased macropinocytosis |
| DBS0350688 | rdeA-/ acaA- | acaA | rdeA | increased cAMP level | decreased sporulation |
| DBS0351475 | regA-/ [act15]: erkA | erkA | regA | delayed slug development |
| DBS0351472 | regA-/ [act15]: regA(R588A,R589A,L594A,I595A,L596A) | regA | delayed development |
| DBS0351284 | regA-/ [act15]: regA(S142A) | regA | aberrant fruiting body morphogenesis | precocious development |
| DBS0351283 | regA-/ [act15]: regA(S142E) | regA | delayed development |
| DBS0351285 | regA-/ [act15]: regA(S413A) | regA | increased mound size | delayed development |
| DBS0351286 | regA-/ [act15]: regA(S413E) | regA | increased mound size | delayed development |
| DBS0351287 | regA-/ [act15]: regA(T676A) | regA | delayed sporulation |
| DBS0351288 | regA-/ [act15]: regA(T676E) | regA | aberrant fruiting body morphogenesis | precocious development |
| DBS0350670 | regA-/ [regA]: regA(D212N) | regA | precocious sporulation |
| DBS0350380 | regA-/ dhkD- | dhkD | regA | aberrant fruiting body morphogenesis |
| DBS0351473 | regA-/ regA(R588A,R589A,L594A,I595A,L596) | regA | precocious sporulation | decreased mound size | increased protein binding | aberrant fruiting body morphogenesis |
| DBS0236891 | regA-/ tagB- | regA | tagB | decreased sporulation |
| DBS0236892 | regA-/ tagC- | regA | tagC | decreased sporulation |
| HM1451 | rev3-/ xpf- | rev3 | xpf | decreased resistance to cisplatin |
| DBS0349937 | rgaA-/ ctxA- | ctxA | rgaA | aberrant cytokinesis | abolished protein localization to cleavage furrow |
| DBS0349936 | rgaA-/ gapA- | gapA | rgaA | aberrant cellular response to fluid shear stress | aberrant cytokinesis | abolished protein localization to cleavage furrow | increased cell motility |
| DBS0350401 | rgaA-/ gapA- | gapA | rgaA | decreased protein localization to cleavage furrow | increased myosin II assembly | aberrant mitotic spindle organization | increased actin filament polymerization | decreased chemotaxis to cAMP | increased protein kinase activation |
| DBS0350406 | rgaA-/ gapA-/ [unk]: myc: gapA(R308E/ K317E) | gapA | rgaA | increased protein kinase activation |
| DBS0350402 | rgaA-/ iqgC- | iqgC | rgaA | decreased myosin II assembly | increased protein kinase activation |
| DBS0350770 | ripA-/ [act15]: GFP: rapA(G12V) | rapA | ripA | decreased protein kinase activation |
| DBS0350115 | ripA-/ [act15]: GFP: rheb(Q64L) | rheb | ripA | increased phagocytosis |
| DBS0350100 | roco4-/ [unk]: roco4(1018-1292(G1179S)) | roco4 | increased catalytic activity |
| DBS0350098 | roco4-/ [unk]: roco4(1018-1292(S1187A)) | roco4 | abolished catalytic activity |
| DBS0350099 | roco4-/ [unk]: roco4(1018-1292(S1189A)) | roco4 | decreased catalytic activity |
| DBS0350178 | rrpA-/ rrpB-/ rrpC- | rrpA | rrpB | rrpC | increased gene expression | decreased gene expression |
| DBS0350189 | rrpA-/ rrpB-/ rrpC-/ [act6]: lacZ/ [RNAi]lacZ | rrpA | rrpB | rrpC | abolished transitive RNA interference |
| DBS0350176 | rrpA-/ rrpC- | rrpA | rrpC | increased gene expression | decreased gene expression |
| DBS0350187 | rrpA-/ rrpC-/ [act6]: lacZ/ [AS]lacZ | rrpA | rrpC | aberrant production of siRNA involved in RNA interference |
| DBS0350182 | rrpA-/ rrpC-/ [act6]: lacZ/ [RNAi]lacZ | rrpA | rrpC | abolished transitive RNA interference |
| DBS0350177 | rrpB-/ rrpC- | rrpB | rrpC | increased gene expression | decreased gene expression |
| DBS0350185 | rrpB-/ rrpC-/ [act6]: lacZ/ [AS]lacZ | rrpB | rrpC | aberrant production of siRNA involved in RNA interference |
| DBS0350184 | rrpB-/ rrpC-/ [act6]: lacZ/ [RNAi]lacZ | rrpB | rrpC | abolished transitive RNA interference |
| DBS0350974 | sadA-/ [act15]: gpaH | gpaH | sadA | aberrant cytokinesis |
| DBS0349790 | sadA-/ [act15]: sadA(1-923): GFP | sadA | decreased cell-substrate adhesion |
| DBS0349792 | sadA-/ [act15]: sadA(S924A/ S925A): GFP | sadA | wild type |
| DBS0349791 | sadA-/ [act15]: sadA(S924E/ S925E): GFP | sadA | decreased cell-substrate adhesion |
| DBS0351566 | sbdS(1-30,TS18,31-274)/ [act15]: eIF(T56K) | eIF6 | sbds | wild type |
| DBS0351524 | scrA-/ [act15]: scrA(R177A,R179A,K180A,R183A,R184A,R187A,K190A,K191A,K194A) | scrA | decreased bleb assembly | increased cellular localization | aberrant pseudopodium formation |
| DBS0351611 | scrA-/ [act15]: scrA(S287,290,301,335,339,384,388,389,430,432,433,437,440A) | scrA | aberrant pseudopodium formation |
| DBS0351522 | scrA-/ [act15]: scrA(S430A,S432A,S433A,S437A,S440A) | scrA | decreased bleb assembly | increased cellular localization | aberrant pseudopodium formation |
| DBS0351523 | scrA-/ [act15]: scrA(S430D,S432D,S433D,S437D,S440D) | scrA | decreased pseudopodium size |
| DBS0350063 | scrA-/ [tet]: scrA/ mhcA- | mhcA | scrA | aberrant cytokinesis |
| DBS0351610 | scrA-/ [tet]: scrA/ wasA- | scrA | wasA | aberrant cell motility | abolished vegetative growth | abolished bleb assembly | aberrant pseudopodium formation |
| DBS0238440 | scrA-/ [unk]: scrA(97-443): GFP | scrA | aberrant cytokinesis | increased vegetative cell size | decreased chemotaxis to cAMP | aberrant cytoskeleton organization |
| SB18 | scrA-/ napA- | napA | scrA | decreased actin filament polymerization | decreased cell motility |
| SB7 | scrA-/ pirA- | pirA | scrA | decreased vegetative cell size |
| DBS0350286 | sec1-/ sec1(M250L/ A296V/ M427L/ S435R/ K505N/ V552D/ H570Q)/ gppA: GFP | gppA | sec1 | abolished contractile vacuole discharge |
| HM1093 | sgkA-/ sgkB- | sgkA | sgkB | decreased resistance to carboplatin | decreased growth rate | decreased resistance to cisplatin |
| DBS0266513 | sigN(group1)- | sigN1 | sigN105-1 | sigN2 | sigN25 | sigN3 | sigN4 | sigN5 | wild type |
| DBS0266514 | sigN(group2)- | DDB_G0271820 | sigN10 | sigN11 | sigN12 | sigN14 | sigN6 | sigN7 | sigN8 | sigN9 | wild type |
| DBS0350860 | sir2D-/ [ecmAO]: lacZ | sir2D | decreased prestalk cell differentiation |
| DBS0350861 | sir2D-/ [pspA]: lacZ | sir2D | aberrant prespore cell differentiation |
| DBS0302657 | smlA-/ cnrN- | cnrN | smlA | decreased fruiting body size |
| DBS0236940 | smlA-/ ctnA- | ctnA | smlA | increased cell-cell adhesion |
| DBS0304496 | smlA-/ sslA1(CR11) | smlA | sslA1 | increased fruiting body size |
| DBS0351063 | sodC-/ [unk]: rasG(C118A) | rasG | sodC | aberrant regulation of GTPase activity |
| DBS0236943 | spkA-1-/ spkA-2- | spkA-1 | spkA-2 | decreased cell-substrate adhesion | aberrant cytokinesis | decreased mound size | decreased chemotaxis rate | decreased establishment of cell polarity | aberrant cell morphology | decreased fruiting body size |
| DBS0236944 | spkA-1-/ spkA-2-/ [act15]: spkA: FLAG | spkA-1 | spkA-2 | aberrant aggregation | decreased chemotaxis rate | aberrant actin filament organization | decreased establishment of cell polarity |
| DBS0350582 | splB-/ pyk3- | pyk3 | splB | abolished gene expression | abolished protein localization to nucleus | aberrant sorocarp development | abolished protein phosphorylation |
| DBS0236948 | spnA-/ arkA- | arkA | spnA | decreased gene expression | increased sorus size | decreased stalk length | delayed gene expression |
| DBS0350223 | stlA-/ stlB- | stlA | stlB | decreased gene expression | increased gene expression | aberrant gene expression | decreased stalk width |
| DBS0350224 | stlA-/ stlB-/ [ecmA]: lacZ | stlA | stlB | decreased prestalk cell differentiation |
| DBS0350637 | tagB-/ [pkaC]: pkaC | pkaC | tagB | aberrant response to biotic stimulus | abolished spore cell differentiation |
| DBS0350672 | tagB-/ pkaR- | pkaR | tagB | decreased sporulation |
| DBS0236974 | tagB-/ psmA1- | psmA1 | tagB | abolished sporulation |
| DBS0350442 | talA-/ sibA- | sibA | talA | wild type |
| DBS0304581 | talA-/ talB- | talA | talB | development arrests at loose mound stage | abolished cell-substrate adhesion | aberrant cytokinesis | abolished cell motility | increased bleb assembly |
| DBS0350713 | talA-/ talB-/ [act15]: talB(K16A) | talA | talB | decreased cell-substrate adhesion |
| DBS0350712 | talB-/ [act15]: talB(K16A) | talB | development arrests at tipped mound stage |
| DBS0351501 | talB-/ pikB- | pikB | talB | aberrant cellular process |
| DBS0351148 | tgrB1-/ tgrB1(1-827): HA | tgrB1 | development arrests at mound stage |
| AK1540 | tgrB1-/ tgrC1- | tgrB1 | tgrC1 | development arrests at loose mound stage | abolished cell-cell self recognition | aberrant oscillatory cAMP signaling |
| AK1664 | tgrB1-/ tgrC1-/ alg9(-19ins) | alg9 | tgrB1 | tgrC1 | decreased sporulation |
| AK1657 | tgrC1-/ (QS38|tgrC1)/ alg9(-19ins) | alg9 | tgrC1 | delayed development | decreased fruiting body size | decreased sporulation |
| JS64 | tipA-/ tipB-/ [act15]: lacZ | tipA | tipB | increased mound size | increased number of mound tips | development arrests at mound stage |
| JS98 | tipA-/ tipC-/ [ecmA]: lacZ | tipA | tipC | development arrests at loose mound stage |
| JS128 | tipA-/ tipD-/ [ecmA]: lacZ | tipA | tipD | development arrests at loose mound stage |
| JS99 | tipB-/ tipC-/ [ecmA]: lacZ | tipB | tipC | increased number of mound tips | development arrests at tipped mound stage |
| JS129 | tipB-/ tipD-/ [ecmA]: lacZ | tipB | tipD | increased number of mound tips | development arrests at tipped mound stage |
| DBS0350729 | tipC-/ [unk]: tipC(2725-3848): GFP | tipC | decreased fruiting body size |
| JS130 | tipC-/ tipD-/ [ecmA]: lacZ | tipC | tipD | development arrests at loose mound stage |
| DBS0350507 | tpp1-/ stpA- | stpA | tpp1 | wild type |
| DBS0351571 | vacA-/ vacB-/ vacC- | vacA | vacB | vacC | decreased cell-substrate adhesion | decreased gene expression | decreased phagocytosis | aberrant phagosome maturation | decreased protein localization | aberrant protein localization |
| DBS0351313 | vasP-/ [act15]: abpB(129-295) | abpB | vasP | aberrant cellular process |
| DBS0351300 | vasP-/ [act15]: eYFP: vasP(S141A) | vasP | decreased protein localization to cell cortex | wild type | decreased lateral pseudopodium retraction | decreased establishment of cell polarity | aberrant actin filament organization |
| DBS0351301 | vasP-/ [act15]: eYFP: vasP(S141D) | vasP | aberrant hyperosmotic response | decreased filopodium formation |
| DBS0350466 | vasP-/ [unk]: vasP(1-197: 221-380) | vasP | wild type |
| DBS0350467 | vasP-/ [unk]: vasP(1-261: 285-380) | vasP | decreased cell motility | abolished filopodium formation |
| DBS0351537 | vasP-/ pirA- | pirA | vasP | increased number of mound tips |
| DBS0351250 | vmp1-/ [act15]: vmp1(G268L): GFP | vmp1 | aberrant aggregation | aberrant protein localization to autophagosome |
| DBS0237050 | warA-/ hbx2- | hbx2 | warA | increased basal disc size | development arrests at mound stage | decreased prespore cell differentiation | increased prestalk O cell differentiation |
| DBS0351509 | wasA-/ [tet]: scrA/ [unk]: GFP: wasA(I173A/ F179A) | scrA | wasA | aberrant pseudopodium formation |
| DBS0351508 | wasA-/ [unk]: GFP: wasA(I173A/ F179A) | wasA | aberrant protein localization to trailing edge | decreased establishment of cell polarity |
| DBS0351185 | washc5-/ [act15]: washc5(N457D): GFP | washc5 | abolished exocytosis |
| DBS0350872 | wshA-/ [act15]: GFP: wshA/ [act15]: vatB: RFP | vatB | wshA | abolished endocytic recycling |
| DBS0350451 | wshA-/ atg1- | atg1 | wshA | wild type |
| DBS0350247 | wshA-/ fam21-/ [act15]: GFP: wshA | fam21 | wshA | aberrant lysosome organization |
| DBS0350058 | yakA-/ keaA- | keaA | yakA | wild type |
| DBS0351199 | yakA-/ pkaC- | pkaC | yakA | aberrant cellular response to stress |
| AK804 | yakA-/ pufA- | pufA | yakA | increased protein kinase activity | increased protein level | aberrant fruiting body morphogenesis | increased growth rate | precocious development |
BACK TO TOP - BACK TO DOWNLOADS INDEX
| Home| Contact dictyBase| SOPs| Site Map |
Supported by NIH (NIGMS and NHGRI)
|
